Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12391642
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 12390453
Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
granted -
US 12391669
Substituted pyrimidines as IRE1 kinase inhibitors
granted -
US 12383582
Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases
granted -
US 12384750
Ras inhibitors
granted -
US 12383538
Use of mTOR inhibitors for prevention of intestinal polyp growth and cancer
granted -
US 12384775
Pyrimid-2-yl-pyrazole compounds as IRAK inhibitors
granted -
US 12384753
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
granted -
US 12384761
Imidazolo indazole compounds as JAK inhibitors
granted -
US 12378241
Pyridine derivative as FGFR and VEGFR dual inhibitors
granted -
US 12377078
Viral inhibitors, the synthesis thereof, and intermediates thereto
granted -
US 12378231
Small molecules as monoacylglycerol lipase (MAGL) inhibitors, compositions and use thereof
granted -
US 12378201
Histone demethylase inhibitors for treating cancers
granted -
CN 120418289
Combination therapy of bispecific binding agents that bind to CLDN18.2 and CD3 with immune checkpoint inhibitors
granted -
US 12371434
MLL1 inhibitors and anti-cancer agents
granted -
US 12371435
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
granted -
US 12365653
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
granted -
US 12365688
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
granted -
US 12365664
Small molecule inhibitors of SRC tyrosine kinase
granted -
US 12365659
Non-polyamine based polyamine transport inhibitors and their use in the treatment of human cancers
granted -
US 12364688
NSD family inhibitors and methods of treatment therewith
granted -
US 12358896
LRRK2 inhibitors and methods of making and using thereof
granted -
US 12358892
Metalloenzyme inhibitors for treating cancers, Alzheimer's disease, hemochromatosis, and other disorders
granted -
US 12357650
Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation
granted